MSOPX
Price
$30.78
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
3.19B
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.32B
Ad is loading...

MSOPX vs RNPEX

Header iconMSOPX vs RNPEX Comparison
Open Charts MSOPX vs RNPEXBanner chart's image
Morgan Stanley Inst Global Opp C
Price$30.78
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets3.19B
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.32B
MSOPX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSOPX vs. RNPEX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSOPX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. MSOPX (3.19B). RNPEX pays higher dividends than MSOPX: RNPEX (0.55) vs MSOPX (0.00). MSOPX was incepted earlier than RNPEX: MSOPX (10 years) vs RNPEX (23 years). MSOPX (1.96) is less costly to investors than RNPEX (0.76). RNPEX is a more actively managed with annual turnover of: 24.00 vs. MSOPX (19.00). RNPEX has a lower initial minimum investment than MSOPX: RNPEX (250) vs MSOPX (1000). MSOPX annual gain was more profitable for investors over the last year : 10.16 vs. RNPEX (5.27). RNPEX return over 5 years is better than : 46.39 vs. MSOPX (12.29).
MSOPXRNPEXMSOPX / RNPEX
Total Expense Ratio1.960.76258%
Annual Report Gross Expense Ratio1.960.76258%
Fund Existence10 years23 years-
Gain YTD5.9192.282259%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.19B142B2%
Annual Yield % from dividends0.000.55-
Returns for 1 year10.165.27193%
Returns for 3 years33.2527.41121%
Returns for 5 years12.2946.3927%
Returns for 10 years103.0364.04161%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings